(hydroxy-2-naphthalenylmethyl)phosphonic acid has been researched along with dasatinib in 1 studies
Studies ((hydroxy-2-naphthalenylmethyl)phosphonic acid) | Trials ((hydroxy-2-naphthalenylmethyl)phosphonic acid) | Recent Studies (post-2010) ((hydroxy-2-naphthalenylmethyl)phosphonic acid) | Studies (dasatinib) | Trials (dasatinib) | Recent Studies (post-2010) (dasatinib) |
---|---|---|---|---|---|
11 | 0 | 5 | 2,707 | 216 | 2,081 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barnett, A; Bu, Y; Clements, J; Cutler, DL; Fang, JWS; Fetterly, G; Gelman, IH; Hangauer, DG; Hegab, T; Kwan, R; Lau, JYN; Smolinski, MP | 1 |
1 other study(ies) available for (hydroxy-2-naphthalenylmethyl)phosphonic acid and dasatinib
Article | Year |
---|---|
Discovery of Novel Dual Mechanism of Action Src Signaling and Tubulin Polymerization Inhibitors (KX2-391 and KX2-361).
Topics: Acetamides; Amino Acid Sequence; Catalytic Domain; Cell Line, Tumor; Drug Discovery; Humans; Molecular Docking Simulation; Morpholines; Protein Kinase Inhibitors; Pyridines; Signal Transduction; src-Family Kinases; Tubulin Modulators | 2018 |